Pathogenetic Role and Clinical Implications of Regulatory RNAs in Biliary Tract Cancer

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2020 Dec 30

PMID 33375055

Citations 5

Authors

Nduka Ofoeyeno

Emmanuel Ekpenyong

Chiara Braconi

Affiliations

Soon will be listed here.

Abstract

Biliary tract cancer (BTC) is characterised by poor prognosis and low overall survival in patients. This is generally due to minimal understanding of its pathogenesis, late diagnosis and limited therapeutics in preventing or treating BTC patients. Non-coding RNA (ncRNA) are small RNAs (mRNA) that are not translated to proteins. ncRNAs were considered to be of no importance in the genome, but recent studies have shown they play essential roles in biology and oncology such as transcriptional repression and degradation, thus regulating mRNA transcriptomes. This has led to investigations into the role of ncRNAs in the pathogenesis of BTC, and their clinical implications. In this review, the mechanisms of action of ncRNA are discussed and the role of microRNAs in BTC is summarised. The scope of this review will be limited to miRNA as they have been shown to play the most significant roles in BTC progression. There is huge potential in miRNA-based biomarkers and therapeutics in BTC, but more studies, research and technological advancements are required before it can be translated into clinical practice for patients.

Citing Articles

Molecular mechanisms of mTOR-mediated cisplatin response in tumor cells.

Maharati A, Rajabloo Y, Moghbeli M Heliyon. 2025; 11(1):e41483.

PMID: 39834411 PMC: 11743095. DOI: 10.1016/j.heliyon.2024.e41483.

Molecular profiling of bladder cancer xenografts defines relevant molecular subtypes and provides a resource for biomarker discovery.

Mokkapati S, Manyam G, Steinmetz A, Tholomier C, Martini A, Choi W Transl Oncol. 2025; 52:102269.

PMID: 39808845 PMC: 11782912. DOI: 10.1016/j.tranon.2024.102269.

A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patients with pancreatic ductal adenocarcinoma.

Li B, Shi M, Wang Y, Li P, Yin X, Zhang G Transl Oncol. 2025; 52:102282.

PMID: 39808844 PMC: 11782853. DOI: 10.1016/j.tranon.2025.102282.

Effects of combined use of compound acidifiers and plant essential oils in feed on the reproductive performance and physiological status of Xianjv chickens.

Wang Z, Zhang C, Wang H, Gu T, Tian Y, Gu Z Poult Sci. 2025; 104(2):104710.

PMID: 39764874 PMC: 11760305. DOI: 10.1016/j.psj.2024.104710.

RNA binding proteins in cardiovascular development and disease.

Verma S, Kuyumcu-Martinez M Curr Top Dev Biol. 2024; 156:51-119.

PMID: 38556427 PMC: 11896630. DOI: 10.1016/bs.ctdb.2024.01.007.

References

Hong D, Kang Y, Borad M, Sachdev J, Ejadi S, Lim H . Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. Br J Cancer. 2020; 122(11):1630-1637. PMC: 7251107. DOI: 10.1038/s41416-020-0802-1. View

Cai J, Xu L, Cai Z, Wang J, Zhou B, Hu H . MicroRNA-146b-5p inhibits the growth of gallbladder carcinoma by targeting epidermal growth factor receptor. Mol Med Rep. 2015; 12(1):1549-55. DOI: 10.3892/mmr.2015.3461. View

Medina P, Slack F . microRNAs and cancer: an overview. Cell Cycle. 2008; 7(16):2485-92. DOI: 10.4161/cc.7.16.6453. View

Liang C, Yang P, Han T, Wang R, Xing X, Si A . Long non-coding RNA DILC promotes the progression of gallbladder carcinoma. Gene. 2019; 694:102-110. DOI: 10.1016/j.gene.2018.12.086. View

Lampis A, Carotenuto P, Vlachogiannis G, Cascione L, Hedayat S, Burke R . MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma. Gastroenterology. 2017; 154(4):1066-1079.e5. PMC: 5863695. DOI: 10.1053/j.gastro.2017.10.043. View

Yang D, Sun Y, Hu L, Zheng H, Ji P, Pecot C . Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. Cancer Cell. 2013; 23(2):186-99. PMC: 3603369. DOI: 10.1016/j.ccr.2012.12.020. View

Tetreault N, De Guire V . miRNAs: their discovery, biogenesis and mechanism of action. Clin Biochem. 2013; 46(10-11):842-5. DOI: 10.1016/j.clinbiochem.2013.02.009. View

Sato K, Glaser S, Francis H, Alpini G . Concise Review: Functional Roles and Therapeutic Potentials of Long Non-coding RNAs in Cholangiopathies. Front Med (Lausanne). 2020; 7:48. PMC: 7045865. DOI: 10.3389/fmed.2020.00048. View

Chang Y, Liu C, Yang J, Liu G, Feng F, Tang J . MiR-20a triggers metastasis of gallbladder carcinoma. J Hepatol. 2013; 59(3):518-27. DOI: 10.1016/j.jhep.2013.04.034. View

10.

Wang S, Ma F, Tang Z, Wu X, Cai Q, Zhang M . Long non-coding RNA H19 regulates FOXM1 expression by competitively binding endogenous miR-342-3p in gallbladder cancer. J Exp Clin Cancer Res. 2016; 35(1):160. PMC: 5048611. DOI: 10.1186/s13046-016-0436-6. View

11.

Wei J, Huang K, Yang C, Kang C . Non-coding RNAs as regulators in epigenetics (Review). Oncol Rep. 2016; 37(1):3-9. DOI: 10.3892/or.2016.5236. View

12.

Eiholm S, Thielsen P, Kromann-Andersen H . Endoscopic brush cytology from the biliary duct system is still valuable. Dan Med J. 2013; 60(7):A4656. View

13.

Liu C, Huang Q, Jin Z, Zhu C, Liu Z, Wang C . miR-21 and KLF4 jointly augment epithelial‑mesenchymal transition via the Akt/ERK1/2 pathway. Int J Oncol. 2017; 50(4):1109-1115. PMC: 5363879. DOI: 10.3892/ijo.2017.3876. View

14.

Wang L, He C, Sui X, Cai M, Zhou C, Ma J . MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN. Oncotarget. 2015; 6(8):5932-46. PMC: 4467412. DOI: 10.18632/oncotarget.3465. View

15.

Li X, Ren Z, Tang J . MicroRNA-34a: a potential therapeutic target in human cancer. Cell Death Dis. 2014; 5:e1327. PMC: 4123066. DOI: 10.1038/cddis.2014.270. View

16.

Kitamura T, Connolly K, Ruffino L, Ajiki T, Lueckgen A, DiGiovanni J . The therapeutic effect of histone deacetylase inhibitor PCI-24781 on gallbladder carcinoma in BK5.erbB2 mice. J Hepatol. 2012; 57(1):84-91. PMC: 3378818. DOI: 10.1016/j.jhep.2012.01.018. View

17.

Cheng Q, Feng F, Zhu L, Zheng Y, Luo X, Liu C . Circulating miR-106a is a Novel Prognostic and Lymph Node Metastasis Indicator for Cholangiocarcinoma. Sci Rep. 2015; 5:16103. PMC: 4632041. DOI: 10.1038/srep16103. View

18.

Baulina N, Kulakova O, Favorova O . MicroRNAs: The Role in Autoimmune Inflammation. Acta Naturae. 2016; 8(1):21-33. PMC: 4837569. View

19.

Dammes N, Peer D . Paving the Road for RNA Therapeutics. Trends Pharmacol Sci. 2020; 41(10):755-775. PMC: 7470715. DOI: 10.1016/j.tips.2020.08.004. View

20.

Shigehara K, Yokomuro S, Ishibashi O, Mizuguchi Y, Arima Y, Kawahigashi Y . Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer. PLoS One. 2011; 6(8):e23584. PMC: 3157401. DOI: 10.1371/journal.pone.0023584. View